Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, op...

oleh O'Shaughnessy Joyce, Sousa Susana, Cruz Josefina, Fallowefield Lesley, Auvinen Paivi, Pulido Catarina, Cvetanovic Ana, Wilks Sharon, Ribeiro Leonor, Burotto Mauricio, Klingbiel Dirk, Messeri Dmitri, Alexandrou Ari, Trask Peter, Fredriksson Judy, Machackova Zuzana, Stamatovic Ljiljana, PHranceSCa study group
Terbitan: 2021